HOME >> MEDICINE >> NEWS
New evidence eases some concerns about bone fracture risk with breast cancer drug

Copenhagen, Denmark: New evidence about the breast cancer drug anastrozole (Arimidex) shows that the incidence of a major side-effect bone fractures appears to stabilise after reaching a peak at two years of treatment, easing some of the concerns about the drug.

This finding is the latest to come from evidence provided by the world's largest international study of breast cancer treatment, the ATAC[1] trial, which compared the aromatase inhibitor anastrozole with breast cancer's current gold standard hormone treatment tamoxifen, and with both treatments combined.

The trial, involving more than 9,000 post menopausal women in 21 countries, last year revealed that over a median follow-up of patients of 33 months, anastrozole enhanced disease-free survival by 19% and cut the incidence of new tumours in the opposite breast by 58% compared to tamoxifen. This represented an absolute difference of 1.8% in favour of anastrozole. An update at 47 months median follow up showed that the gap had widened to an absolute difference of 2.6% in favour of the newer drug. Overall survival comparisons from the trial should be available next year.

Professor Anthony Howell, chairman of the ATAC steering committee, told a news briefing at ECCO 12 the European Cancer Conference, that while it was clear that further results were adding to the evidence that anastrozole may in the future supplant tamoxifen doctors needed to be cautious. "We should still wait for that overall survival data next year," he said.

A concern about anastrozole has been the risk of bone fractures. Depriving the body of oestrogen reduces the risk of breast cancer recurring because many breast cancers 'feed' off this hormone. But, one consequence of oestrogen deprivation is that bones become vulnerable. Aromatase inhibitors such as anastrozole produce profound oestrogen deprivation so it would not be unexpected that women on anastrozole might be more at risk of fractures than those on
'"/>

Contact: Margaret Willson
m.willson@mwcommunications.org.uk
45-3252-4163
Federation of European Cancer Societies
24-Sep-2003


Page: 1 2 3

Related medicine news :

1. More evidence of cannabis-induced psychosis
2. Not enough evidence that multivitamins prevent infections in the elderly
3. Emotional memory study reveals evidence for a self-reinforcing loop
4. Influenza vaccination programmes for children in USA and Canada based on little evidence
5. Scientific evidence for diets: dont believe everything you read
6. New evidence of retroviral involvement in amyotrophic lateral sclerosis
7. Two studies find evidence that sunlight may have beneficial influence on cancer
8. Study finds no evidence of a cancer personality
9. Penn researchers add more evidence to demonstrate role of COX inhibitors in heart-disease risk
10. USC researchers find evidence that progesterone signaling influences ovarian cancer risk
11. Chamomile tea: New evidence supports health benefits

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/17/2017)... Verdes, CA (PRWEB) , ... February 17, 2017 ... ... emotional flow is Dr. Carol Francis' goals for each and every ... Conference, Dr. Carol Francis will demonstrate five different brainwave tools which help energize ...
(Date:2/17/2017)... ... February 17, 2017 , ... Qualis Health, one ... in the 8th Annual DecisionHealth Platinum Awards in recognition of its innovative healthcare ... is recognized across multiple award categories, highlighting four of the organization’s current programs:, ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... by fall 2017 season , Trinity Health and the U.S. Soccer Foundation announced ... Success program in underserved communities. Soccer for Success, the Foundation’s soccer mentoring program, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica ... focusing on all facets of clinical trial planning and management. Pharmica discussed the ... and more. In addition, attendees stopping by Pharmica’s booth were able to demo ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... exhibitor at Molecular Medicine Tri-Conference February 20 – 22 in San Francisco. As ... showcase its anatomic and molecular pathology workflow solution, as well as its new ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... SCOTTSDALE, Ariz. , Feb. 16, 2017 HealthInfoNet ... announced today it is partnering with Orion Health on the ... of all Maine residents, clinical information ... hospitals and over 500 ambulatory care sites. Pending ... deploy Orion Health,s Amadeus , a precision medicine platform ...
(Date:2/16/2017)...   Spectralink Corporation , the global leader ... manufacturing and hospitality industries, today announced the results ... support features of its PIVOT™:SC (8744) ... study, conducted by The Tolly Group, showed quantifiable ... with dedicated hardware scanners. Spectralink introduced ...
(Date:2/16/2017)... TEL AVIV, Israel , Feb. 16, 2017 ... company, today announced the appointment of Harvey ... and Chief Executive Officer of ARIAD Pharmaceuticals, Inc., ... of Medinol US Inc., effective immediately.  Dr. Berger, ... areas of business development, global strategy, new business ...
Breaking Medicine Technology:
Cached News: